612 related articles for article (PubMed ID: 32323177)
1. Gut Microbiota and Alimentary Tract Injury.
Chen Y; Wu G; Zhao Y
Adv Exp Med Biol; 2020; 1238():11-22. PubMed ID: 32323177
[TBL] [Abstract][Full Text] [Related]
2. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
[TBL] [Abstract][Full Text] [Related]
3. Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development.
Kang M; Martin A
Semin Immunol; 2017 Aug; 32():3-13. PubMed ID: 28465070
[TBL] [Abstract][Full Text] [Related]
4. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
Yu LC
J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
[TBL] [Abstract][Full Text] [Related]
5. The contribution of microbial biotechnology to sustainable development goals: microbiome therapies.
O'Toole PW; Paoli M
Microb Biotechnol; 2017 Sep; 10(5):1066-1069. PubMed ID: 28696041
[TBL] [Abstract][Full Text] [Related]
6. Dysbiotic events in gut microbiota: impact on human health.
Schippa S; Conte MP
Nutrients; 2014 Dec; 6(12):5786-805. PubMed ID: 25514560
[TBL] [Abstract][Full Text] [Related]
7. Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD.
Casén C; Vebø HC; Sekelja M; Hegge FT; Karlsson MK; Ciemniejewska E; Dzankovic S; Frøyland C; Nestestog R; Engstrand L; Munkholm P; Nielsen OH; Rogler G; Simrén M; Öhman L; Vatn MH; Rudi K
Aliment Pharmacol Ther; 2015 Jul; 42(1):71-83. PubMed ID: 25973666
[TBL] [Abstract][Full Text] [Related]
8. METABOLIC DYSBIOSIS OF THE GUT MICROBIOTA AND ITS BIOMARKERS.
Sitkin SI; Tkachenko EI; Vakhitov TY
Eksp Klin Gastroenterol; 2016 Jul; 12(12):6-29. PubMed ID: 29889418
[TBL] [Abstract][Full Text] [Related]
9. Study Insights into Gastrointestinal Cancer through the Gut Microbiota.
Kong F; Cai Y
Biomed Res Int; 2019; 2019():8721503. PubMed ID: 31341907
[TBL] [Abstract][Full Text] [Related]
10. The gut microbiome and irritable bowel syndrome: State of art review.
Salem AE; Singh R; Ayoub YK; Khairy AM; Mullin GE
Arab J Gastroenterol; 2018 Sep; 19(3):136-141. PubMed ID: 29935865
[TBL] [Abstract][Full Text] [Related]
11. High-Fat Diet and Antibiotics Cooperatively Impair Mitochondrial Bioenergetics to Trigger Dysbiosis that Exacerbates Pre-inflammatory Bowel Disease.
Lee JY; Cevallos SA; Byndloss MX; Tiffany CR; Olsan EE; Butler BP; Young BM; Rogers AWL; Nguyen H; Kim K; Choi SW; Bae E; Lee JH; Min UG; Lee DC; Bäumler AJ
Cell Host Microbe; 2020 Aug; 28(2):273-284.e6. PubMed ID: 32668218
[TBL] [Abstract][Full Text] [Related]
12. The fingerprint of the human gastrointestinal tract microbiota: a hypothesis of molecular mapping.
Tomasello G; Mazzola M; Jurjus A; Cappello F; Carini F; Damiani P; Gerges Geagea A; Zeenny MN; Leone A
J Biol Regul Homeost Agents; 2017; 31(1):245-249. PubMed ID: 28337900
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori may participate in the development of inflammatory bowel disease by modulating the intestinal microbiota.
Bai X; Jiang L; Ruan G; Liu T; Yang H
Chin Med J (Engl); 2022 Mar; 135(6):634-638. PubMed ID: 35234697
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders.
Lopetuso LR; Petito V; Graziani C; Schiavoni E; Paroni Sterbini F; Poscia A; Gaetani E; Franceschi F; Cammarota G; Sanguinetti M; Masucci L; Scaldaferri F; Gasbarrini A
Dig Dis; 2018; 36(1):56-65. PubMed ID: 28683448
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota, inflammatory bowel disease and colorectal cancer.
Quaglio AEV; Grillo TG; De Oliveira ECS; Di Stasi LC; Sassaki LY
World J Gastroenterol; 2022 Aug; 28(30):4053-4060. PubMed ID: 36157114
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota, dysbiosis and colon lavage.
Drago L; Valentina C; Fabio P
Dig Liver Dis; 2019 Sep; 51(9):1209-1213. PubMed ID: 31358483
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition.
Putignani L; Del Chierico F; Vernocchi P; Cicala M; Cucchiara S; Dallapiccola B;
Inflamm Bowel Dis; 2016 Feb; 22(2):487-504. PubMed ID: 26588090
[TBL] [Abstract][Full Text] [Related]
18. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer.
Jackson DN; Theiss AL
Gut Microbes; 2020 May; 11(3):285-304. PubMed ID: 30913966
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota and IBD: causation or correlation?
Ni J; Wu GD; Albenberg L; Tomov VT
Nat Rev Gastroenterol Hepatol; 2017 Oct; 14(10):573-584. PubMed ID: 28743984
[TBL] [Abstract][Full Text] [Related]
20. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
Raftery AL; Tsantikos E; Harris NL; Hibbs ML
Front Immunol; 2020; 11():2144. PubMed ID: 33042125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]